These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 7540878

  • 1. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy.
    Saito M, Asakura H, Jokaji H, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Aoshima K, Matsuda T.
    Blood Coagul Fibrinolysis; 1995 Feb; 6(1):60-4. PubMed ID: 7540878
    [Abstract] [Full Text] [Related]

  • 2. Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis.
    Koseki M, Asada N, Uryu H, Takeuchi M, Asakura H, Matsue K.
    Int J Hematol; 2007 Dec; 86(5):403-6. PubMed ID: 18192107
    [Abstract] [Full Text] [Related]

  • 3. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
    Kario K, Matsuo T, Kodama K, Matsuo M, Yamamoto K, Kobayashi H.
    Haemostasis; 1992 Dec; 22(4):179-86. PubMed ID: 1468720
    [Abstract] [Full Text] [Related]

  • 4. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
    Okamoto K, Takaki A, Takeda S, Katoh H, Ohsato K.
    Haemostasis; 1992 Dec; 22(1):17-24. PubMed ID: 1387863
    [Abstract] [Full Text] [Related]

  • 5. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
    Yamada S, Asakura H.
    Int J Hematol; 2021 Jan; 113(1):15-23. PubMed ID: 33175341
    [Abstract] [Full Text] [Related]

  • 6. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
    Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Aoshima K, Matsuda T.
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691
    [Abstract] [Full Text] [Related]

  • 7. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
    Nakagawa T, Saito H, Watanabe Y, Sato M, Murakawa E.
    Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
    [Abstract] [Full Text] [Related]

  • 8. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon].
    Ohsato K, Okamoto K.
    Nihon Rinsho; 1993 Jan; 51(1):50-5. PubMed ID: 8381885
    [Abstract] [Full Text] [Related]

  • 9. Hemostatic molecular markers before the onset of disseminated intravascular coagulation.
    Wada H, Sakuragawa N, Mori Y, Takagi M, Nakasaki T, Shimura M, Hiyoyama K, Nisikawa M, Gabazza EC, Deguchi K, Kazama M, Shiku H.
    Am J Hematol; 1999 Apr; 60(4):273-8. PubMed ID: 10203100
    [Abstract] [Full Text] [Related]

  • 10. Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers.
    Wada H, Gabazza E, Nakasaki T, Shimura M, Hiyoyama K, Deguchi K, Nishikawa M, Sakuragawa N, Shiku H.
    Semin Thromb Hemost; 2000 Apr; 26(1):17-21. PubMed ID: 10805276
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Disseminated intravascular coagulation in transfusion-associated graft-versus-host disease. Report of two cases.
    Murakawa M, Okamura T, Harada M, Esaki T, Kamura T, Shibuya T, Niho Y.
    Ann Clin Lab Sci; 1995 Apr; 25(1):31-8. PubMed ID: 7762966
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]

  • 15. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
    Tsuda T, Hayashi H, Tsurumi N, Kuroda M, Takai Y, Kimura I.
    Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
    [No Abstract] [Full Text] [Related]

  • 16. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases].
    Shibata T, Ishii T, Tomo T, Kaneko K, Nasu M, Magari Y, Fukushima K.
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
    Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Shiku H.
    Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.